Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",41809,226,1.16 [0.85-1.59],0.3577164873123359
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",43249,327,1.09 [0.83-1.43],0.5475991873045636
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",42814,2281,1.09 [0.98-1.21],0.1033910958599494
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Candidiasis,43282,694,1.18 [1.00-1.40],0.056513159104488
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,41975,5787,1.07 [1.01-1.15],0.0304405541586562
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),42167,5259,1.19 [1.11-1.26],2.652069519464961e-07
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,42863,2006,1.12 [1.01-1.24],0.0322790650096301
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,43129,143,1.29 [0.91-1.82],0.1461118991799944
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,39906,1561,1.24 [1.11-1.39],0.0001487273955046
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,38536,1762,1.26 [1.13-1.40],2.9781260938933985e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,38399,410,1.17 [0.92-1.48],0.195288942173867
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,30397,3241,1.13 [1.04-1.23],0.0028313657786286
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,38141,636,1.20 [0.99-1.44],0.0577972503102109
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,43220,2363,1.12 [1.01-1.23],0.0278633549915828
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Mycoses,43404,816,1.15 [0.98-1.35],0.0926981627971272
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,42058,1525,1.21 [1.08-1.36],0.0007497026437014
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,43300,1717,1.21 [1.08-1.35],0.0006059923452703
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,41186,329,1.09 [0.83-1.43],0.5237660699497022
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,43495,79,1.37 [0.89-2.12],0.1535685594367631
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other septicaemia,43092,1509,1.24 [1.11-1.39],0.0001460085777942
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,43115,129,0.97 [0.60-1.56],0.8932238863449551
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other viral diseases,43354,258,1.16 [0.88-1.53],0.2818503234625666
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",43327,231,1.13 [0.84-1.52],0.4303718414940526
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,41222,689,1.01 [0.83-1.24],0.8905776612210172
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,40986,453,0.87 [0.66-1.15],0.3203984875704438
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,41026,169,1.20 [0.85-1.69],0.3077239682403555
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,43455,90,1.12 [0.68-1.86],0.6537817424930201
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,43379,264,0.92 [0.66-1.29],0.635611329466649
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Viral warts,43203,88,0.72 [0.36-1.43],0.3499351626834843
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],43230,115,0.83 [0.47-1.45],0.5091016705698492
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign lipomatous neoplasm,42992,494,0.81 [0.62-1.07],0.1369049206435569
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,43346,100,0.57 [0.28-1.16],0.1230375292463562
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,43305,107,0.80 [0.44-1.44],0.4551423728356004
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,19918,108,1.20 [0.78-1.84],0.4142641078706102
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",42928,2425,0.88 [0.78-0.99],0.0274146403078272
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm of meninges,43470,98,1.61 [1.23-2.11],0.0005830392991031
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,43384,114,1.45 [1.05-2.01],0.0225085752093874
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,43451,180,1.14 [0.80-1.61],0.4665871617475041
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm of ovary,23467,147,0.66 [0.38-1.14],0.139324480774117
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Ascending colon,43454,622,0.90 [0.72-1.14],0.3801536156296583
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Caecum,43461,505,0.89 [0.69-1.15],0.3871770908305449
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",43305,124,0.85 [0.49-1.45],0.547049153599484
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Descending colon,43455,375,1.03 [0.79-1.35],0.8153709771564503
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Rectum,43380,590,0.89 [0.71-1.13],0.3448050044553897
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,43292,1062,0.96 [0.81-1.13],0.6389614313727134
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Transverse colon,43445,708,0.91 [0.73-1.13],0.3931374775730356
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Carcinoma in situ of breast,19054,117,1.05 [0.69-1.60],0.8156692163633772
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19124,135,0.98 [0.64-1.50],0.9250710576821995
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",34646,90,0.87 [0.47-1.61],0.6517447109464571
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",34669,113,1.29 [0.88-1.89],0.1866001585425282
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",43408,199,1.16 [0.85-1.58],0.3621108171799605
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Haemangioma, any site",43409,194,1.12 [0.81-1.56],0.4925459147744632
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Leiomyoma of uterus,22684,489,1.04 [0.84-1.29],0.7040514728354772
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Lung cancer and mesothelioma,30204,578,1.10 [0.88-1.39],0.4079894142597731
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Lymphoid leukaemia,34643,87,1.11 [0.67-1.85],0.691292999745811
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",34868,312,1.17 [0.91-1.49],0.2246646341087276
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",34891,335,1.31 [1.04-1.64],0.0205795734605306
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19252,163,1.07 [0.73-1.56],0.7396200651119245
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",34698,142,1.01 [0.64-1.59],0.9630988210978146
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",34730,174,1.04 [0.70-1.54],0.8514057750878719
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",34731,175,1.25 [0.90-1.74],0.190752021206694
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19218,129,0.96 [0.61-1.52],0.8597832141021297
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",34714,158,0.85 [0.53-1.38],0.5221113268861677
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",16617,1150,1.05 [0.90-1.22],0.5644007715041426
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",34750,194,1.09 [0.77-1.55],0.6240113209633744
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",34687,131,1.59 [1.20-2.12],0.0014103693162956
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,34730,174,0.97 [0.65-1.45],0.8772498266776434
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Melanocytic naevi,43161,350,1.03 [0.80-1.33],0.8135124574050974
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Melanocytic naevi of trunk,43429,153,0.84 [0.53-1.34],0.468077953764582
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Melanoma in situ,34608,134,0.98 [0.62-1.54],0.922545771896834
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",34709,153,1.28 [0.92-1.78],0.143535956760315
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",34825,269,1.42 [1.15-1.77],0.0012848983826052
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",34954,398,1.02 [0.78-1.34],0.8857723873033114
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",34724,168,1.40 [1.06-1.85],0.018493285466608
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Other benign neoplasms of skin,43196,275,0.82 [0.58-1.17],0.2805411218387794
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",36345,1789,1.05 [0.94-1.18],0.3782545485703592
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",36438,1882,1.06 [0.95-1.18],0.3187687029804146
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,42989,583,1.17 [0.97-1.40],0.0940519522708909
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,40391,147,1.38 [1.00-1.90],0.0485008609315738
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,42533,127,1.35 [0.98-1.88],0.0680214881475165
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,42193,4792,1.13 [1.05-1.21],0.0005061158307495
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,41099,78,1.17 [0.69-2.00],0.563639563407061
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,42791,86,1.44 [0.99-2.10],0.0554744268417756
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,42716,2472,1.13 [1.02-1.24],0.0148256411325844
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,42714,2470,1.13 [1.02-1.24],0.0146512168453308
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,40385,141,1.08 [0.71-1.64],0.7136576464257408
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,42963,1942,1.13 [1.02-1.26],0.0226331043649375
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,42901,196,1.10 [0.78-1.54],0.5872625991699958
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,42509,103,1.12 [0.69-1.80],0.6447080728609434
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,42513,107,0.86 [0.48-1.52],0.592921330843748
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,43167,462,1.30 [1.07-1.57],0.0068490759670483
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,43325,88,1.03 [0.61-1.74],0.9200035265310698
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",43090,385,1.31 [1.07-1.61],0.0090149593375619
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,41189,168,1.37 [1.03-1.82],0.0316470748639019
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,33773,508,1.22 [0.99-1.50],0.0601490767338049
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,40548,195,1.18 [0.85-1.64],0.3225600377048914
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,40569,216,1.10 [0.79-1.52],0.5732489377204208
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,33355,90,1.38 [0.91-2.09],0.1279580585722368
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,40414,107,1.32 [0.90-1.94],0.1562053445323077
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,39486,385,1.09 [0.84-1.40],0.5152308084175086
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",42736,893,1.10 [0.93-1.31],0.2483458297461143
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,42297,454,1.03 [0.81-1.31],0.7932655040659904
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,42016,173,1.28 [0.93-1.75],0.1250933715655254
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,42923,2616,1.08 [0.99-1.19],0.0969629982083484
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,37994,2545,1.10 [1.00-1.20],0.0537288943006685
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",33372,107,0.94 [0.54-1.62],0.8166649238179629
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",40164,136,0.65 [0.36-1.18],0.1550577551230265
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,33731,466,1.17 [0.94-1.46],0.1556046728327398
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,33367,102,1.36 [0.94-1.97],0.1001750498064454
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,39158,5893,1.01 [0.94-1.08],0.7788614877812374
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,33600,335,1.19 [0.92-1.53],0.1902137384005317
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,34198,933,1.17 [1.01-1.37],0.0376029424714606
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,43360,539,1.26 [1.05-1.51],0.0110396138946432
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,43039,218,1.36 [1.06-1.76],0.0161535382023819
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,33472,207,1.09 [0.77-1.54],0.6445951037963197
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",33366,101,0.87 [0.48-1.57],0.6348901349192476
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,42593,2565,1.12 [1.02-1.23],0.0137747980091556
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,33675,410,1.39 [1.13-1.71],0.0018330649988444
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,33719,454,1.27 [1.03-1.57],0.0281536368697115
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",34327,1062,0.90 [0.75-1.08],0.2656790673340895
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,33446,181,0.99 [0.65-1.50],0.9622724384878988
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,43027,206,1.24 [0.92-1.67],0.152150386628956
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,34265,1000,1.20 [1.04-1.38],0.0143178045678869
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,34072,807,1.10 [0.92-1.31],0.2936076450799089
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,39208,107,1.34 [0.93-1.94],0.1196373758992263
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,41589,8324,1.07 [1.01-1.13],0.0143684175591652
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,40102,74,0.98 [0.53-1.83],0.9541899600457308
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,40124,96,0.92 [0.53-1.62],0.7847412184008872
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,43192,3233,0.97 [0.88-1.07],0.5828058767856465
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",43194,3229,0.97 [0.88-1.07],0.5755234547171035
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,40113,85,0.87 [0.45-1.65],0.6592503512396044
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,42913,2026,1.08 [0.97-1.20],0.1513913150403128
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",35864,2599,1.20 [1.10-1.32],7.888233122031868e-05
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,43476,349,1.29 [1.02-1.64],0.0333428931164346
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,41967,124,1.13 [0.73-1.75],0.5953789042963853
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,41068,181,1.03 [0.71-1.50],0.8631949744489995
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,41128,241,0.85 [0.58-1.24],0.4030385571231832
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",33536,271,1.33 [1.06-1.67],0.0129552576397328
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,39603,260,1.17 [0.87-1.57],0.3050637008356489
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,3559,140,1.05 [0.68-1.61],0.8380114920680439
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,3792,418,0.98 [0.75-1.29],0.9085433655657752
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,39446,103,1.39 [0.90-2.14],0.1381833019441535
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,3499,81,1.18 [0.68-2.02],0.5604196955595085
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,42452,3109,1.14 [1.05-1.25],0.002721656755694
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,42389,546,1.14 [0.93-1.40],0.2127694124555166
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,39718,617,1.09 [0.89-1.33],0.4222941969817222
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,34503,1238,1.17 [1.03-1.34],0.0193058846864844
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",43300,410,1.04 [0.81-1.34],0.7727149739498237
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),41604,277,1.32 [1.02-1.71],0.0362628883817772
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Angina pectoris,39789,1977,1.04 [0.93-1.17],0.5032200851046693
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Aortic aneurysm,41735,408,1.22 [0.97-1.53],0.0833247945966641
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,41421,94,1.14 [0.68-1.91],0.6225295588657751
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",41653,326,1.26 [0.99-1.62],0.0655259511740673
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,26987,3134,1.05 [0.96-1.16],0.2793445342630271
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,AV-block,36755,711,0.96 [0.78-1.19],0.7115047782681196
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",43398,689,1.14 [0.95-1.36],0.1583553778849824
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Cardiac arrest,24168,315,1.39 [1.11-1.76],0.005008124304092
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Cardiomyopathy,36329,285,1.09 [0.81-1.46],0.5562594142689773
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",36201,157,0.85 [0.53-1.38],0.5152640085368243
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,43492,76,1.45 [0.93-2.26],0.1024947160735259
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Conduction disorders,37773,1729,1.12 [0.99-1.26],0.0665473250726409
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,41245,3465,1.05 [0.96-1.14],0.3270818833094364
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,38083,12774,1.02 [0.97-1.06],0.5246874951260534
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,DVT of lower extremities,41198,442,1.02 [0.79-1.30],0.8914479065716405
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Endocarditis,36160,116,1.42 [1.00-2.01],0.0518648925383823
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Heart failure, strict",43150,1801,1.24 [1.11-1.38],0.0001148799189521
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Hypertension,39612,10914,1.01 [0.96-1.06],0.7837624790821951
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Hypertension, essential",39626,10928,1.01 [0.96-1.06],0.7719868763077442
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Hypertension, portal",43202,129,1.13 [0.74-1.75],0.5672681545684464
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",29016,318,1.46 [1.19-1.80],0.0003562588997404
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,28862,164,1.73 [1.38-2.16],1.4985591969500346e-06
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Hypotension,43265,1904,1.12 [1.00-1.25],0.0421605307273553
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,41988,177,1.24 [0.89-1.71],0.2003068248807856
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",41537,3725,1.01 [0.93-1.10],0.7845560509366843
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",42888,921,1.11 [0.94-1.30],0.2235212211018314
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Left bundle-branch block,36641,597,1.32 [1.11-1.57],0.0014192123371614
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,42720,1417,1.09 [0.95-1.24],0.2134501488445813
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",39002,1190,1.08 [0.94-1.25],0.269487361753908
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",43336,265,1.25 [0.96-1.63],0.1016173698290726
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",43443,514,0.89 [0.69-1.15],0.3731901409973472
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Oesophageal varices,40843,87,1.25 [0.77-2.01],0.3677987340948619
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other aneurysm,41451,124,0.92 [0.55-1.53],0.7532655490752511
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other arrhythmias,36765,721,1.16 [0.98-1.39],0.0853235051579525
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,41496,169,1.31 [0.94-1.83],0.1142490486387613
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,41721,394,1.09 [0.85-1.40],0.498308519562011
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,36344,300,1.03 [0.76-1.39],0.8587033037207006
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other disorders of veins,40906,150,1.01 [0.65-1.56],0.971934624594014
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,40839,83,1.07 [0.63-1.85],0.7942692703726557
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,41144,107,1.02 [0.61-1.69],0.9532687269995046
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,40972,216,1.01 [0.70-1.46],0.9539757950908422
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,37738,1694,1.20 [1.08-1.35],0.0013150989675586
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,41448,87,1.14 [0.68-1.91],0.6316936804032501
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,42237,910,1.07 [0.90-1.26],0.4517575005660548
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,42455,592,1.37 [1.16-1.62],0.0001575491926558
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",42037,1000,1.11 [0.95-1.30],0.1744724937081779
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,24413,560,1.19 [0.98-1.44],0.0847547757135388
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Peripheral artery disease,41939,664,1.09 [0.89-1.33],0.4019991826445213
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),41330,574,1.06 [0.86-1.30],0.6037487431872612
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Pulmonary embolism,42650,787,1.02 [0.85-1.23],0.8062492252379595
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,43373,1073,1.12 [0.97-1.30],0.1362666456613049
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Right bundle-branch block,36617,573,1.18 [0.97-1.44],0.0938787970318254
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Secondary right heart disease,42447,584,1.38 [1.17-1.63],0.000126096072515
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,41348,311,1.35 [1.08-1.70],0.0097239858112944
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",42866,1055,1.11 [0.95-1.29],0.1823606753825593
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",42834,1120,1.10 [0.95-1.28],0.1986487622275097
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,41944,100,1.07 [0.66-1.74],0.7895089681931571
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,41455,129,1.25 [0.86-1.81],0.2449954257390667
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Transient ischemic attack,42340,373,0.95 [0.71-1.26],0.7002855146620386
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,41739,436,1.12 [0.88-1.41],0.3634524954809852
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Varicose veins,41451,695,1.08 [0.90-1.30],0.3887019934705528
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,41351,143,0.88 [0.54-1.44],0.6066212389547508
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Venous thromboembolism,43101,1239,1.04 [0.90-1.20],0.6165213909165165
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",43286,609,1.06 [0.87-1.30],0.5478713853886824
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",38121,2399,1.07 [0.97-1.18],0.1833439276098614
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Any mental disorder,42411,6689,1.08 [1.02-1.15],0.0100500526604485
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",43209,717,1.09 [0.91-1.31],0.3477194118710442
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",38387,2665,1.10 [1.00-1.21],0.0392072932134571
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",35863,141,1.18 [0.81-1.72],0.3778603159633917
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Smoking dependency,42595,2315,1.05 [0.95-1.17],0.3569439948347829
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",38472,2750,1.10 [1.00-1.21],0.0610723136847325
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Vascular dementia,42699,212,0.94 [0.64-1.39],0.7664661146039717
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Alzheimer disease,43494,565,1.02 [0.82-1.27],0.8559474875499958
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",29499,103,0.71 [0.37-1.39],0.3197130693768664
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Bell's palsy,40513,137,1.36 [0.99-1.86],0.0556615640826625
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,41213,837,0.91 [0.75-1.10],0.3343444293353041
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Cerebral cysts,42817,378,1.21 [0.97-1.51],0.0848618981918116
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,43359,520,1.19 [0.97-1.45],0.0947594782517465
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,42671,91,1.11 [0.67-1.82],0.6912945427155712
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,43467,109,1.17 [0.76-1.80],0.4863093349590072
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",42556,117,1.26 [0.85-1.85],0.2474643436557198
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Epilepsy,40917,473,1.06 [0.85-1.32],0.6228056653417342
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,42691,2247,1.04 [0.94-1.16],0.4237689774059812
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,43416,705,1.00 [0.82-1.21],0.981513569806166
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Falls/tendency to fall,42494,4253,1.09 [1.01-1.17],0.028543412523325
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Generalized epilepsy,42859,91,0.78 [0.41-1.49],0.4591753396992375
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Hemiplegia,43245,406,1.20 [0.96-1.51],0.1109453926205223
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Hydrocephalus,42541,102,1.13 [0.71-1.80],0.6112986514057863
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,43459,117,0.88 [0.52-1.49],0.6420510012845099
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,40505,129,0.79 [0.46-1.34],0.3748963174686435
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,40510,134,1.14 [0.77-1.70],0.516678808928928
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Memory loss,42452,194,0.92 [0.61-1.37],0.6747322482027388
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Migraine,41037,593,1.00 [0.82-1.23],0.9929422214917846
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",43377,539,0.98 [0.79-1.22],0.8703925509946405
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Motor neuron disease,29680,248,0.84 [0.58-1.22],0.3611805919359032
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,43197,181,0.86 [0.56-1.31],0.4737545251490604
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",42388,2012,1.03 [0.92-1.15],0.6605870617686689
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Neurological diseases,41007,6113,1.05 [0.99-1.12],0.1140332891662222
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,42885,305,0.88 [0.63-1.23],0.4634241286529108
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",41050,674,0.92 [0.74-1.14],0.4316725460089666
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",43365,478,1.16 [0.94-1.44],0.172807672703571
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,34819,1079,0.98 [0.84-1.16],0.8518347098876514
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,42559,120,1.16 [0.76-1.76],0.492747855231653
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other disorders of nervous system,42673,234,1.03 [0.74-1.45],0.8536181346038274
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,42962,251,1.04 [0.76-1.43],0.7872204100968418
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other facial nerve disorders,40538,162,1.27 [0.92-1.74],0.1444095728782533
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other headache syndromes,40542,98,0.95 [0.55-1.64],0.8498579793656346
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other neurological diseases,43297,858,1.16 [1.00-1.36],0.0577069217432364
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other sleep disorders,41365,921,1.13 [0.96-1.32],0.1402176000321743
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Parkinson's disease,43449,414,0.97 [0.75-1.26],0.824457508666438
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,42533,94,1.29 [0.89-1.87],0.1777864949718454
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Restless leg syndrome,43491,111,1.05 [0.65-1.69],0.8441632445425837
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Sleep apnoea,43099,799,1.12 [0.94-1.33],0.1892059989592143
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Small fibre neuropathy,42966,79,0.91 [0.49-1.70],0.7774302927840874
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,43466,294,0.78 [0.55-1.12],0.1811992386048779
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,40463,87,1.47 [1.03-2.09],0.0317756992910631
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,43494,570,1.02 [0.82-1.27],0.8518393940136495
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),42632,205,0.95 [0.64-1.41],0.8094050796684245
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,42541,159,1.29 [0.94-1.78],0.1189271208794923
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,42824,669,0.92 [0.74-1.15],0.4714558864014611
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,43217,393,1.03 [0.78-1.36],0.8474899593036572
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,41800,89,0.98 [0.56-1.71],0.940914804727579
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,41809,98,0.78 [0.42-1.44],0.4259543339904202
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",43309,91,1.55 [1.11-2.17],0.0098739863828106
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,43067,251,0.87 [0.60-1.26],0.4552869458033467
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",3506,87,1.10 [0.64-1.90],0.7208610078747374
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,4252,162,1.02 [0.67-1.54],0.9314628208526474
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,42544,162,0.82 [0.51-1.32],0.4215348009458604
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,43155,1731,0.99 [0.87-1.13],0.8819751662423185
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",42866,1155,1.06 [0.92-1.23],0.3999799506961363
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,42089,378,1.14 [0.90-1.45],0.2656518091657511
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",43359,1204,0.97 [0.84-1.14],0.7368927348307425
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,43479,116,1.36 [0.96-1.93],0.0844334177848781
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,43244,1089,0.96 [0.82-1.13],0.6493492364315512
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",43423,607,0.92 [0.73-1.15],0.4630858124553072
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,43338,305,0.88 [0.64-1.23],0.4566557208716956
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,41813,102,1.45 [1.01-2.09],0.0464277450304579
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,41824,113,1.06 [0.66-1.71],0.8027578848938068
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,41805,94,0.83 [0.45-1.53],0.5508528950872196
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,43339,1173,0.97 [0.83-1.14],0.7159521342587414
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,42484,318,0.85 [0.61-1.19],0.3398109623713214
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,42229,74,1.08 [0.62-1.90],0.7828632774471507
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,42978,162,0.67 [0.39-1.14],0.1370283841396131
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,43275,459,1.00 [0.78-1.28],0.9830267347419388
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,42481,326,0.97 [0.73-1.30],0.8515598567591123
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,43216,183,0.75 [0.47-1.20],0.2309474537209552
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,42926,760,1.07 [0.89-1.28],0.4638795868272967
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,42615,233,1.22 [0.92-1.61],0.1728032945447681
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,40824,3645,1.01 [0.93-1.11],0.7531175765443401
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,43218,402,0.98 [0.74-1.28],0.8575930362520086
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,43455,259,1.01 [0.73-1.40],0.945980414550164
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,42396,685,1.05 [0.86-1.27],0.6487631065307375
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,42926,110,0.63 [0.33-1.23],0.1797592756209209
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,43457,94,1.26 [0.82-1.94],0.2865402227425234
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,41851,140,1.08 [0.72-1.64],0.7053294019764235
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,41962,251,0.90 [0.63-1.29],0.5787543418459661
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,41621,197,1.10 [0.78-1.56],0.5906229085336975
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,42245,90,0.91 [0.51-1.62],0.7448696988823402
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",41533,109,1.01 [0.62-1.63],0.9837506992869302
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,42310,144,0.56 [0.31-1.02],0.0575589325118757
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",42488,322,0.93 [0.68-1.27],0.6544418134212491
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,41914,203,1.00 [0.69-1.44],0.9796341812645116
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,41610,186,0.85 [0.56-1.28],0.4320184037621075
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,41558,134,1.05 [0.68-1.63],0.8226463827245148
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,40168,2989,1.04 [0.95-1.14],0.4224050138977644
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,41835,124,1.20 [0.81-1.77],0.3579610018677789
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,43070,688,1.11 [0.93-1.33],0.255808828622862
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,42481,99,0.86 [0.47-1.57],0.6214128162819681
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),42650,268,1.13 [0.85-1.51],0.387339103619872
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,43118,147,1.39 [1.03-1.87],0.031612426999101
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,43417,201,1.31 [0.99-1.72],0.0604343544669236
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,43273,217,1.11 [0.81-1.52],0.515856088340271
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,43074,103,1.01 [0.61-1.67],0.9637101277097092
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,43083,112,0.73 [0.40-1.35],0.3167760944869131
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,43315,1459,1.16 [1.03-1.31],0.0133247211670914
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,42901,1045,1.20 [1.04-1.38],0.0097609464125852
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,42066,210,0.82 [0.53-1.25],0.3493100988528467
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,41995,139,1.14 [0.77-1.69],0.5125207757117397
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Acute pharyngitis,43074,122,0.83 [0.48-1.42],0.4954646357064838
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,43311,359,0.96 [0.72-1.27],0.7613595708333707
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,43056,104,1.17 [0.76-1.81],0.4689759971577811
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,All influenza,40177,192,1.35 [1.01-1.79],0.0412258550549905
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),40173,188,1.37 [1.03-1.81],0.0306154665530013
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Allergic asthma (mode),29828,202,1.15 [0.84-1.57],0.382912512786194
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Allergic rhinitis,43291,475,1.00 [0.79-1.26],0.9721104367335096
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",32180,2999,1.06 [0.97-1.16],0.1944588793848007
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",32577,2951,1.06 [0.97-1.16],0.2185423329816609
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),42817,232,1.26 [0.95-1.67],0.1021792275082346
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",40117,132,1.15 [0.75-1.74],0.5252410281358426
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Bronchiectasis,37653,587,1.18 [0.98-1.42],0.0847572144212587
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",37163,97,1.19 [0.75-1.88],0.4683864121901242
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,41771,4705,1.10 [1.02-1.18],0.011089071176276
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",41157,123,1.26 [0.88-1.82],0.2048942479754917
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Chronic sinusitis,41290,256,1.01 [0.73-1.38],0.9647690632782934
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",43157,1973,1.15 [1.03-1.29],0.0103610957390677
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Deviated nasal septum,41228,194,0.93 [0.64-1.37],0.7253170987433473
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,39981,8779,1.07 [1.02-1.13],0.0085456779872495
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",41675,641,1.08 [0.89-1.31],0.4253884646601154
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Early onset COPD,41726,542,1.26 [1.03-1.55],0.0281893976272754
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Emphysema,37600,534,1.14 [0.91-1.42],0.2456072028522058
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,41256,493,1.24 [1.02-1.52],0.0308411111681367
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Influenza and pneumonia,43112,3127,1.18 [1.09-1.28],8.457842786278518e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Interstitial lung disease,41311,548,1.25 [1.04-1.51],0.0200000571580624
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Later onset COPD,41765,1431,1.10 [0.96-1.26],0.1779522165129298
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,43470,518,1.11 [0.90-1.38],0.3378335246667341
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Nasal polyp,41222,188,0.88 [0.58-1.33],0.5327787748866569
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,43059,1602,1.08 [0.95-1.22],0.2521451310032899
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other diseases of pleura,43092,3320,1.17 [1.08-1.27],0.0001735814919612
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,42467,1433,1.03 [0.90-1.17],0.6825313505203598
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other pleural conditions,39856,84,1.36 [0.90-2.06],0.1479226951153321
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,43322,680,1.21 [1.02-1.44],0.032718005914873
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,43309,2180,1.14 [1.03-1.26],0.0132889934696386
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Pleural effusion,41405,1633,1.20 [1.07-1.34],0.001368955524239
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Pleural plaque,40040,268,1.32 [1.01-1.71],0.0421879864881954
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",42696,2711,1.19 [1.09-1.30],8.583353690274014e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,43353,401,1.07 [0.83-1.38],0.6113791148970373
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Pneumothorax,39978,206,1.04 [0.73-1.49],0.829154851608773
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Pollen allergy,43458,406,1.00 [0.78-1.29],0.9844208653565156
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Pulmonary oedema,42751,109,0.96 [0.56-1.66],0.8928141150921438
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Respiratory insufficiency,29715,89,1.24 [0.78-1.99],0.367406491064004
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,43027,1570,1.08 [0.95-1.23],0.2183623824400687
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,41510,476,1.00 [0.79-1.26],0.992331175618524
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Viral pneumonia,40390,405,1.04 [0.80-1.36],0.7517405714734045
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",42841,333,0.87 [0.62-1.21],0.4007656322368912
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,20084,188,1.40 [1.06-1.85],0.0178500122748109
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,30820,110,1.64 [1.24-2.16],0.0004495294276705
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Acute appendicitis,43212,239,1.29 [1.01-1.65],0.0416771789528502
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Acute gastritis,32810,143,1.32 [0.95-1.85],0.1031159546241991
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Acute pancreatitis,40403,310,1.00 [0.74-1.35],0.9770791576408474
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Acute peritonitis,42701,151,1.29 [0.93-1.80],0.1313979399317767
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Alcoholic liver disease,41993,123,1.31 [0.90-1.90],0.1537230594880343
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Barrett oesophagus,33396,729,1.10 [0.92-1.31],0.2998911160831042
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",40265,172,1.08 [0.73-1.59],0.6984771086333754
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",42800,172,1.07 [0.72-1.58],0.7423253825315468
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Cholecystitis,40424,331,1.04 [0.79-1.38],0.7600783483333016
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Cholelithiasis,41776,1683,1.03 [0.91-1.17],0.6250433248126017
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Chronic gastritis,33170,503,1.03 [0.82-1.29],0.8171532069419931
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Chronic pancreatitis,40172,79,1.35 [0.88-2.09],0.1722983089654721
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",43251,178,1.24 [0.88-1.74],0.2225636523224833
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Coeliac disease,40789,206,1.61 [1.35-1.93],2.2688486938966786e-07
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Collagenous colitis,40660,134,1.09 [0.73-1.63],0.6812488455441896
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,43232,319,1.10 [0.84-1.43],0.5064999760764314
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Constipation,43067,2737,1.08 [0.98-1.19],0.1131472247702382
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Crohn disease,40671,145,1.09 [0.74-1.61],0.6578673426383654
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",42901,104,1.23 [0.81-1.85],0.3285954707972063
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Crohn's disease NAS,40660,134,1.02 [0.66-1.56],0.9309315047818588
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Dental caries,42247,387,1.00 [0.77-1.30],0.9809217901030818
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,39057,3704,1.04 [0.96-1.13],0.360138925762275
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of appendix,43276,303,1.25 [1.00-1.57],0.0532202875775996
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of liver,43290,1420,1.06 [0.93-1.22],0.3574471329233306
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",39835,7168,1.03 [0.97-1.10],0.2779541560452949
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",42781,921,1.00 [0.84-1.18],0.9672682786453408
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of peritoneum,43345,795,1.14 [0.97-1.34],0.1220338356785809
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,42047,187,1.06 [0.74-1.52],0.7410050308498843
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of salivary glands,41811,105,1.48 [1.09-2.01],0.0118512821888362
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of the digestive system,42969,2386,1.07 [0.97-1.18],0.175233817840444
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of tongue,41827,183,0.98 [0.67-1.44],0.9258010795765654
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",42465,2372,1.06 [0.96-1.17],0.2788016356601988
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,36009,5299,0.97 [0.91-1.05],0.487123469939968
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Duodenal ulcer,32992,325,1.09 [0.82-1.43],0.556974733926431
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",43341,254,1.09 [0.80-1.49],0.5702070444656785
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,43346,93,0.94 [0.56-1.59],0.8202436022767445
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,42084,214,1.10 [0.78-1.55],0.5951334444519385
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,30958,248,1.07 [0.79-1.45],0.6613724613426393
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Functional dyspepsia,33582,915,1.01 [0.86-1.19],0.901009266687931
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gastric ulcer,33273,606,1.09 [0.89-1.34],0.3985074197966676
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,36835,4168,1.02 [0.94-1.10],0.6651047575593736
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,33563,896,1.06 [0.90-1.26],0.4700627026698648
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,33677,13868,1.04 [1.00-1.09],0.0641279787478267
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,GI-bleeding,42518,1935,0.96 [0.85-1.08],0.5003993816995285
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,41964,104,1.15 [0.74-1.78],0.53729876016567
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,32332,2104,1.00 [0.89-1.11],0.929460499787732
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",41976,106,1.17 [0.74-1.85],0.5111715994550414
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Hernia,40750,5397,1.05 [0.98-1.12],0.1526631823775943
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Impacted teeth,43357,87,0.97 [0.57-1.64],0.9049285167468828
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Impaction of intestines,30805,95,0.90 [0.51-1.59],0.7158435078031335
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Inguinal hernia,36879,1526,1.12 [0.99-1.26],0.0830207452407864
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",35521,168,1.03 [0.70-1.53],0.8659628953403544
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,30866,156,1.09 [0.75-1.59],0.657693460658078
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Intestinal malabsorption,40829,246,1.54 [1.29-1.85],2.001754812341489e-06
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,31643,933,0.94 [0.79-1.12],0.4916138343430518
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,43445,603,0.99 [0.79-1.23],0.904413376959054
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,41790,1264,1.07 [0.94-1.23],0.295748383432361
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,42202,1676,1.05 [0.93-1.19],0.4002631109009812
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Oesophageal obstruction,32974,307,1.28 [1.01-1.62],0.0375544708665455
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Oesophagitis,33675,1008,1.15 [1.00-1.33],0.0523459498825133
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,43402,225,1.17 [0.88-1.56],0.2819925085657083
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,35468,115,1.03 [0.63-1.68],0.9071219471716192
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,33005,2295,0.94 [0.84-1.05],0.2906983286745114
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,40565,472,0.96 [0.74-1.23],0.7362962590108053
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,40357,264,1.03 [0.76-1.40],0.8506091850012619
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of intestine,33651,2941,0.93 [0.84-1.03],0.1779152037043637
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of intestines,40125,9415,0.98 [0.93-1.03],0.437642777021493
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,41790,343,1.21 [0.97-1.51],0.0915476961266699
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of liver,43024,1154,1.05 [0.91-1.22],0.5145954218077144
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,33777,1110,1.16 [1.02-1.33],0.028335066635259
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of pancreas,40347,254,1.26 [0.97-1.65],0.0841533515467126
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,43234,684,1.12 [0.94-1.34],0.1950673547146143
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,34248,1581,1.07 [0.95-1.21],0.2546095492611741
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,42543,1960,0.95 [0.84-1.07],0.3768977310299246
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,42150,290,0.85 [0.60-1.20],0.3508541019932686
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,33528,2818,1.06 [0.96-1.16],0.2343422622716292
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),35996,3329,1.07 [0.99-1.17],0.1051300842803138
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,42035,165,1.23 [0.89-1.72],0.2115110151068226
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,42001,1475,1.08 [0.96-1.23],0.1989763263383946
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",31287,577,1.04 [0.85-1.28],0.6859446391344528
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,43328,110,0.98 [0.62-1.56],0.94053271954835
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,31528,818,1.05 [0.89-1.25],0.5680138379208757
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",40839,256,1.30 [1.02-1.67],0.0366751711534114
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Recurring oral aphthae,43472,97,0.65 [0.33-1.29],0.2168106647670863
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,41869,197,0.84 [0.55-1.26],0.397818977900456
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Toxic colitis,40618,92,1.38 [0.93-2.04],0.1076605393592732
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,33125,458,1.25 [1.02-1.52],0.0314877595494524
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Ulcerative colitis,40793,267,0.95 [0.68-1.31],0.7363300702859893
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",40749,223,0.84 [0.57-1.24],0.3903550484114049
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Umbilical hernia,35794,441,0.80 [0.59-1.07],0.1370973373102826
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,31012,302,0.73 [0.50-1.05],0.0905125275642607
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Ventral hernia,35778,425,1.06 [0.83-1.35],0.6465171446674058
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Volvulus,30840,130,1.05 [0.68-1.61],0.8355015917611922
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,43365,471,1.13 [0.91-1.39],0.2591104275232743
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,42956,133,1.26 [0.90-1.78],0.1776498012905195
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,40103,272,1.08 [0.81-1.43],0.6009258842168556
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,42406,1167,1.04 [0.89-1.21],0.6039851463884749
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",41537,298,1.01 [0.75-1.37],0.9321299324256136
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,40465,634,1.18 [0.98-1.42],0.0874262190595324
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,42975,465,1.09 [0.87-1.36],0.4407060049170859
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,43309,799,1.12 [0.95-1.32],0.1877264911580548
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,42588,78,1.07 [0.62-1.85],0.8030942736538338
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,40856,5314,1.04 [0.97-1.11],0.2692613188541397
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,42722,726,1.01 [0.84-1.22],0.9090595532305694
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,42500,504,1.05 [0.85-1.31],0.6294208159949967
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,42817,1578,1.05 [0.92-1.19],0.4859730280684928
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",43464,92,0.92 [0.53-1.62],0.782643924711449
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,39938,107,1.35 [0.95-1.92],0.0932334453831478
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,42082,86,0.93 [0.51-1.71],0.8221813776146617
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,42958,448,1.00 [0.78-1.28],0.9964099907475136
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,40591,760,0.92 [0.75-1.12],0.407942465025228
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,39940,109,1.08 [0.68-1.72],0.7490881611590792
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,43346,135,1.04 [0.67-1.62],0.8563602378776783
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,41530,291,1.11 [0.84-1.47],0.468333337769215
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,43144,321,1.12 [0.86-1.46],0.4059269219645667
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,42610,100,0.84 [0.45-1.57],0.5802943869255384
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,39940,109,1.00 [0.61-1.63],0.985911310658274
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,42528,2697,1.05 [0.96-1.16],0.2983898775077793
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",40653,822,0.91 [0.75-1.10],0.3306471567168529
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,39947,116,1.04 [0.65-1.67],0.8601733756471457
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,43342,519,1.13 [0.92-1.38],0.2369566274660497
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,42624,114,1.26 [0.86-1.85],0.2419162717083018
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,43247,424,1.18 [0.95-1.46],0.1367914276380427
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,43407,513,1.14 [0.93-1.39],0.2095210250742147
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,40047,216,1.07 [0.78-1.47],0.6675810726426488
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,40283,452,0.90 [0.69-1.17],0.4309153649862708
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,43390,496,1.15 [0.94-1.41],0.1694122822503881
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",40211,380,1.24 [0.98-1.57],0.074776534596546
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,43438,227,0.92 [0.64-1.34],0.6766983272943923
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,37291,186,1.00 [0.69-1.45],0.99940988245588
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,39579,9473,1.00 [0.95-1.06],0.8723307816921424
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,37213,7107,1.02 [0.96-1.08],0.5442453998383439
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,37236,131,0.73 [0.42-1.27],0.2669972352955025
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,37744,252,0.84 [0.58-1.21],0.3479420680908148
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,37789,297,1.14 [0.88-1.48],0.3146870457000162
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,43077,153,1.26 [0.91-1.73],0.1618638963435635
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",37655,163,0.70 [0.42-1.19],0.1897873582805164
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,32031,1925,1.04 [0.93-1.16],0.5243092187209961
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",43252,325,1.01 [0.76-1.35],0.94444513065509
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,38215,723,1.08 [0.90-1.30],0.3870670920005672
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,36767,12197,1.03 [0.99-1.08],0.1728330588833293
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,40170,198,0.93 [0.63-1.38],0.7190059572110872
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,37356,251,0.89 [0.61-1.28],0.5152749915839574
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,38071,966,0.91 [0.77-1.09],0.3087192572346586
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,41915,4423,1.02 [0.94-1.10],0.6402431648999422
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,37572,467,0.81 [0.61-1.07],0.1360024598994288
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,37488,383,1.11 [0.89-1.39],0.3626493774202319
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,37342,237,0.83 [0.57-1.20],0.3201503086643272
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,42370,121,0.67 [0.36-1.23],0.1962436658286103
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,32928,2822,1.01 [0.92-1.12],0.7783024268821614
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,31078,972,1.15 [0.98-1.34],0.0846034818063019
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",43360,956,1.14 [0.97-1.34],0.1078374475932589
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,30234,128,1.00 [0.65-1.54],0.987500456326114
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),30671,565,1.03 [0.85-1.25],0.7729555564470032
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,37615,510,0.99 [0.79-1.24],0.9239584079581794
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,31183,1077,0.92 [0.79-1.09],0.3480818787541665
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,37584,92,1.27 [0.84-1.94],0.2614570135563234
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,38543,1051,1.05 [0.90-1.23],0.5333957721563343
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,37995,503,0.91 [0.71-1.17],0.4651675723958782
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,31108,1002,0.91 [0.77-1.08],0.2849146174190955
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,37234,129,0.81 [0.47-1.38],0.4359953035452801
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",37205,100,1.28 [0.87-1.89],0.2043279992755947
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,40092,120,1.25 [0.84-1.87],0.2709753682163325
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,42854,2882,1.08 [0.99-1.18],0.0801080175211501
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,41866,1894,1.09 [0.98-1.22],0.0975846265804442
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",43250,755,1.13 [0.95-1.34],0.1725291997526475
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,34291,4185,1.03 [0.96-1.12],0.3818777319447323
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,30211,105,0.94 [0.56-1.55],0.795384065837361
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,37259,154,1.19 [0.84-1.67],0.3356167522827192
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,30197,91,1.18 [0.73-1.89],0.505444672337012
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),30318,212,0.92 [0.63-1.32],0.6439982028544411
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,40379,407,1.03 [0.80-1.32],0.8175099207180563
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,40600,628,1.08 [0.90-1.31],0.3989269325602846
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,43440,164,1.50 [1.17-1.93],0.0016359695119179
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",40496,3004,1.05 [0.96-1.15],0.2743059842332014
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,37270,165,1.27 [0.95-1.71],0.1060606370510186
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),30345,239,0.68 [0.44-1.04],0.076358022861292
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,38699,1207,0.96 [0.82-1.12],0.5669293279844925
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,33747,3641,1.00 [0.92-1.08],0.9478260323623792
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,42407,158,0.85 [0.53-1.36],0.4943468009890088
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,43462,129,1.29 [0.92-1.81],0.1408483780555578
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,37242,137,0.88 [0.54-1.44],0.6118924729342723
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",39187,2082,1.16 [1.05-1.28],0.0036359793165508
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,37248,143,0.94 [0.59-1.49],0.7855095664738954
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,32841,2735,1.03 [0.94-1.14],0.5250603071616411
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,40167,195,0.73 [0.46-1.16],0.1833595518800893
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,37193,88,1.22 [0.80-1.84],0.3568827563441186
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,37756,264,0.88 [0.61-1.26],0.484143630444061
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,38014,909,1.21 [1.05-1.40],0.0090085675076877
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,42853,604,1.14 [0.95-1.38],0.1626556928026651
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,38443,951,1.00 [0.85-1.19],0.9662779493630884
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,43270,734,1.07 [0.90-1.29],0.4433385299515445
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,43456,90,0.79 [0.41-1.52],0.4818902553750009
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,37426,321,0.99 [0.74-1.31],0.9284176307922496
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,34437,1280,0.96 [0.82-1.12],0.5629597238591921
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,38074,969,1.10 [0.94-1.28],0.2194558836594978
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],37496,391,0.89 [0.67-1.18],0.4299488643337725
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",30201,95,0.75 [0.39-1.45],0.3983827254584515
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,34275,4169,1.04 [0.96-1.12],0.3124667563980617
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,31193,1087,0.98 [0.83-1.15],0.7844528043487771
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,42639,390,0.99 [0.76-1.30],0.9680519795601766
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",43381,105,1.58 [1.18-2.11],0.0020632466289851
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",39871,83,0.72 [0.35-1.50],0.3781687495821596
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,30238,132,1.26 [0.91-1.75],0.1697425885408518
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,37666,174,1.06 [0.73-1.54],0.7607570297367834
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,30872,766,1.13 [0.96-1.33],0.1412622383042444
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,37622,517,1.01 [0.81-1.27],0.914130848154526
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,37927,435,1.31 [1.09-1.58],0.0036241558082545
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,37801,309,0.98 [0.72-1.32],0.8836022836194248
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,33998,101,1.32 [0.91-1.92],0.1473702521895159
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",43463,97,0.87 [0.48-1.57],0.6357232514970421
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,38097,992,1.04 [0.89-1.21],0.6574819550798308
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],42409,160,1.40 [1.07-1.83],0.0155898283132749
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,41438,4333,1.06 [0.99-1.14],0.1192178588095165
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",37332,227,1.09 [0.80-1.49],0.5871872756158409
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,38392,900,1.05 [0.88-1.24],0.6055296668506887
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,41089,382,0.93 [0.70-1.24],0.6254300483266555
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,37822,330,1.12 [0.86-1.45],0.3927650112262033
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,40061,2569,1.03 [0.93-1.14],0.5530384937483304
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,39179,1687,1.08 [0.96-1.22],0.2088674552524111
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],37194,89,1.28 [0.85-1.94],0.2416914177869454
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,42491,242,1.45 [1.18-1.77],0.0003870230459676
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,37379,274,0.74 [0.50-1.08],0.1228533511998907
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,37239,134,1.26 [0.90-1.78],0.1838355913413673
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),30202,96,1.22 [0.80-1.88],0.3521840707788809
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Acute renal failure,41927,2514,1.30 [1.19-1.42],3.181119166153654e-09
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17598,87,0.93 [0.53-1.63],0.7876179644260949
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,22937,100,0.86 [0.49-1.51],0.6030408732691378
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,42967,523,0.94 [0.74-1.20],0.6114436294963099
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,42588,144,1.38 [0.99-1.91],0.0583091198746118
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,41676,2263,1.23 [1.12-1.35],2.793163986520978e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,43154,106,1.67 [1.26-2.23],0.0003837218288993
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,43121,491,1.18 [0.95-1.46],0.1341160675674717
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Cystitis,38409,378,1.16 [0.91-1.46],0.2247326055738236
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Dialysis,39524,111,1.67 [1.26-2.23],0.0004320865376996
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,18908,2766,0.99 [0.90-1.10],0.8924175589397637
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23121,284,1.19 [0.93-1.51],0.1587961209978364
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Endometriosis,17659,148,1.09 [0.76-1.56],0.6530444228085523
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",17844,333,1.00 [0.77-1.29],0.9887907672440728
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18371,860,0.99 [0.83-1.18],0.9242946919623162
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,36334,8885,1.06 [1.00-1.11],0.0411439019098988
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,43173,125,1.28 [0.87-1.88],0.2113727675135764
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Hydrocele,16314,172,0.94 [0.61-1.44],0.7694946326460741
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,39361,465,1.20 [0.97-1.47],0.0906493310427381
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,18319,2177,1.03 [0.92-1.16],0.5629450214569106
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23064,340,0.93 [0.69-1.24],0.6117360113609687
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16337,195,0.96 [0.64-1.42],0.8224327690202212
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Irregular menses,23128,106,1.18 [0.82-1.71],0.3789255909888319
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Menorrhagia,17773,262,0.88 [0.63-1.23],0.4433042250449376
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,38156,125,0.72 [0.40-1.28],0.2644168549076243
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,19604,2093,0.98 [0.87-1.09],0.6826786411315842
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,16241,99,1.17 [0.73-1.88],0.5106116157158491
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17627,116,0.82 [0.48-1.42],0.4809871335287854
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",43477,106,1.08 [0.68-1.73],0.7382452181821155
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",43475,110,1.35 [0.94-1.94],0.1030680103626451
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,41748,3717,1.09 [1.00-1.18],0.0429581173619859
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,39239,1208,1.10 [0.95-1.26],0.1947251637232301
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,22937,100,1.55 [1.19-2.01],0.0009834508988367
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,43386,756,1.22 [1.04-1.44],0.0161492282608469
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16402,260,0.80 [0.55-1.17],0.2541050561110769
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16379,237,1.25 [0.93-1.66],0.1368969579087955
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,16333,191,1.16 [0.82-1.65],0.395988570240621
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,43432,116,1.06 [0.67-1.66],0.811268104409717
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,40875,2844,1.14 [1.04-1.24],0.0041718285267883
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,22899,175,0.89 [0.59-1.35],0.5890835740405871
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17645,134,0.97 [0.62-1.52],0.9045226334385884
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",17843,332,1.01 [0.77-1.33],0.926751283406568
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17612,101,1.07 [0.68-1.69],0.7667842447195417
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17688,177,0.73 [0.45-1.19],0.2015320102367307
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,39439,543,1.16 [0.96-1.42],0.1308827726001365
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,42876,246,1.27 [0.97-1.66],0.088365240666493
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17771,260,1.06 [0.80-1.41],0.6818180789998551
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17603,92,0.81 [0.44-1.49],0.494310317936009
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18059,548,1.18 [0.99-1.40],0.0634446070473933
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,17650,139,1.11 [0.76-1.63],0.5885152911837502
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18014,503,1.10 [0.90-1.34],0.353337613844752
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,43136,88,1.37 [0.91-2.06],0.1290958334066781
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16367,225,0.88 [0.59-1.31],0.5300589256787278
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,43133,4237,1.19 [1.11-1.28],1.717390043408077e-06
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",39092,196,1.20 [0.89-1.62],0.2425060450708477
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,39608,195,1.14 [0.81-1.61],0.4484529176825687
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,42536,92,1.12 [0.70-1.82],0.6309390172614924
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Urethral stricture,38399,368,1.01 [0.77-1.32],0.9397452162410868
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Urolithiasis,43098,654,1.06 [0.87-1.28],0.5864602491360498
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17632,121,0.86 [0.51-1.45],0.5763957914080837
